Quince Therapeutics (QNCX)

• Market cap: $15M
• 1 day: -37.06%
• 5 days: -94.46%
• 1 month: -94.79%
• 3 months: -89.7%
• 6 months: -89.7%
• Year to date: -94.33%
• 1 year: -89.38%
• 5 years: -99.54%
• 10 years: -99.48%
• Sector: Healthcare
• Industry: Biotechnology

About: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Employees: 36